Cargando…

The new B-cell-specific exon 1B of the CD5 mRNA favors autoimmunity by preventing the membrane expression of CD5

Detalles Bibliográficos
Autores principales:	Renaudineau, Y, Haget, N, Le Goff, P, Youinou, P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833675/ http://dx.doi.org/10.1186/ar738

Ejemplares similares

Two promoters for the CD5 gene: one operating in T cells and activated B cells and another restricted to resting B cells
por: Renaudineau, Y, et al.
Publicado: (2002)

Cell-free Fc-γ receptors IIIb, autoantibodies and related immune complexes trigger the production of G-CSF and GM-CSF in nonorgan-specific autoimmune diseases
por: Durand, V, et al.
Publicado: (2002)

Anti-Fcgamma receptor (FcgammaR) autoantibodies (Ab) delay apoptosis of polymorphonuclear cells (PMN) in systemic autoimmune diseases by inducing the production of G-CSF and GM-CSF
por: Durand, V, et al.
Publicado: (2001)

Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases
por: Alonso-Ramirez, Ruby, et al.
Publicado: (2010)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

Experimental autoimmune myasthenia gravis and CD5+ B-lymphocyte expression.
por: Lee, K. W., et al.
Publicado: (1999)

IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cells
por: Lee, Jae Ho, et al.
Publicado: (2011)

Human SHBG mRNA Translation Is Modulated by Alternative 5′-Non-Coding Exons 1A and 1B
por: Pinós, Tomàs, et al.
Publicado: (2010)

SR proteins regulate V(6) exon splicing of CD44 pre-mRNA
por: Loh, Tiing Jen, et al.
Publicado: (2016)

Transitional B cells and CD21low in patients with ataxia-telangiectasia
por: Bichuetti-Silva, Danielli Christinni, et al.
Publicado: (2015)

CD4(+)CD25(+) T-Cells Control Autoimmunity in the Absence of B-Cells
por: Mariño, Eliana, et al.
Publicado: (2009)

CD4(+) T Cell Help Impairs CD8(+) T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity
por: Kurts, Christian, et al.
Publicado: (1997)

Role of CD5/CD5L interactions in the homeostasis of regulatory lymphocyte subpopulations and the control of autoimmune disorders
por: Fenutría, Rafael, et al.
Publicado: (2011)

Mesangial Cell-Specific Antibodies Are Central to the Pathogenesis of Lupus Nephritis
por: Seret, Guillaume, et al.
Publicado: (2012)

Cd5 Maintains Tolerance in Anergic B Cells
por: Hippen, Keli L., et al.
Publicado: (2000)

Molecular cloning of candidate antigens recognized by anti-endothelial cell antibodies
por: Revelen, R, et al.
Publicado: (2002)

Association of myelodysplastic syndrome with CD5+, CD23+ monoclonal B-cell lymphocytosis
por: Sandes, Alex F, et al.
Publicado: (2012)

CD8(+) T cells undergo activation and programmed death-1 repression in the liver of aged Ae2(a,b)(−/−) mice favoring autoimmune cholangitis
por: Concepcion, Axel R., et al.
Publicado: (2015)

Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg)
por: Noh, Joonyong, et al.
Publicado: (2010)

Aberrant expansion of CXCR5(+ )memory CD4 T cells in patients with systemic lupus erythematosus
por: Choi, Jin-Young, et al.
Publicado: (2014)

CD5-Positive B Lymphocytes after Kidney Transplantation
por: Zieliński, Maciej, et al.
Publicado: (2021)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

Long term immune reconstitution after immunoablation and autologous CD34 cell therapy in autoimmune diseases
por: Thiel, AT, et al.
Publicado: (2002)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Investigation of genetic variants regulating the expression of metabotropic glutamate receptor, subtype 5 (GRM5) mRNA in human brain
por: Wang, Jian, et al.
Publicado: (2012)

CD22 Exon 12 Deletion as an Independent Predictor of Poor Treatment Outcomes in B-ALL
por: Qazi, Sanjive, et al.
Publicado: (2023)

Disturbed B-lymphocytes selection in autoimmune lymphoproliferative syndrome
por: Janda, Aleš, et al.
Publicado: (2015)

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies
por: Ang, Zhiwei, et al.
Publicado: (2023)

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets
por: Forsthuber, Thomas G., et al.
Publicado: (2018)

Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c(+) B cells
por: Malle, Louise, et al.
Publicado: (2023)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
por: Ma, Xiao‐bo, et al.
Publicado: (2018)

CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen
por: Schmieg, John J., et al.
Publicado: (2021)

Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
por: Moers, C, et al.
Publicado: (2001)

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
por: Fiorina, Paolo, et al.
Publicado: (2008)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)

Prognostic significance of aberrant CD5 expression in B-cell leukemia
por: Jaseb, Kaveh, et al.
Publicado: (2019)

Extrafollicular IgD(−)CD27(−)CXCR5(−)CD11c(−) DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19
por: Allard-Chamard, Hugues, et al.
Publicado: (2023)

Meeting Abstracts from the 5(th) B Chromosome Conference
Publicado: (2023)

Intratumoral CXCR5(+)CD8(+)T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer
por: Wang, Jieti, et al.
Publicado: (2021)

Targeting IRF5 inhibition in human B cells: identification of new functional roles that implicate IRF5 in systemic lupus erythematosus B-cell pathology
por: De, Saurav, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9ch7sq57sil5nni4auv9n4pkfa